{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T09:51:49Z","timestamp":1791971509847,"version":"4.3.4"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2017,3,27]],"date-time":"2017-03-27T00:00:00Z","timestamp":1490572800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"The Department of Health Policy Research Programme and the Scottish Government","award":["PR-ST-0614-00008"],"award-info":[{"award-number":["PR-ST-0614-00008"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Neuropathol"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1007\/s00401-017-1703-0","type":"journal-article","created":{"date-parts":[[2017,3,26]],"date-time":"2017-03-26T22:46:30Z","timestamp":1490568390000},"page":"221-240","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":112,"title":["Amyloid-\u03b2 accumulation in the CNS in human growth hormone recipients in the UK"],"prefix":"10.1007","volume":"134","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3614-9638","authenticated-orcid":false,"given":"Diane L.","family":"Ritchie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Adlard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander H.","family":"Peden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne","family":"Lowrie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret","family":"Le Grice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberley","family":"Burns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosemary J.","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Yull","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Keogh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick F.","family":"Chinnery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark W.","family":"Head","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James W.","family":"Ironside","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,3,27]]},"reference":[{"key":"1703_CR1","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/nature11632","volume":"491","author":"GR Abecasis","year":"2012","unstructured":"1000 Genomes Project Consortium, Abecasis GR, Auton A, Brooks LD, DePristo MA, Durbin RM, Handsaker RE et al (2012) An integrated map of genetic variation from 1,092 human genomes. Nature 491:56\u201365","journal-title":"Nature"},{"key":"1703_CR2","doi-asserted-by":"crossref","first-page":"e1003685","DOI":"10.1371\/journal.pgen.1003685","volume":"9","author":"BA Benitez","year":"2013","unstructured":"Benitez BA, Karch CM, Cai Y, Jin SC, Cooper B, Carrell D et al (2013) The PSEN1, p. E318G variant increases the risk of Alzheimer\u2019s disease in APOE-\u025b4 carriers. PLoS Genet 9:e1003685","journal-title":"PLoS Genet"},{"key":"1703_CR3","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/nrneurol.2010.4","volume":"6","author":"K Blennow","year":"2010","unstructured":"Blennow K, Hampel H, Weiner M, Zetterberg H (2010) Cerebrospinal fluid and plasma biomarkers in Alzheimer\u2019s disease. Nat Rev Neurol 6:131\u2013144","journal-title":"Nat Rev Neurol"},{"key":"1703_CR4","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.tracli.2013.02.029","volume":"20","author":"JP Brandel","year":"2013","unstructured":"Brandel JP, Peckeu L, Ha\u00efk S (2013) The French surveillance network of Creutzfeldt\u2013Jakob disease. Epidemiological data in France and worldwide. Transfus Clin Biol 20:395\u2013397","journal-title":"Transfus Clin Biol"},{"key":"1703_CR5","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF00308809","volume":"82","author":"Braak E Braak","year":"1991","unstructured":"Braak H,\u00a0Braak E (1991) Neuropathological staging of Alzheimer-related changes. Acta Neuropathol 82:239\u2013259","journal-title":"Acta Neuropathol"},{"key":"1703_CR6","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s00401-006-0127-z","volume":"112","author":"H Braak","year":"2006","unstructured":"Braak H, Alafuzoff I, Arzberger T, Kretzschmar H, Del Tredici K (2006) Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry. Acta Neuropathol 112:389\u2013404","journal-title":"Acta Neuropathol"},{"key":"1703_CR7","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1097\/NEN.0b013e318232a379","volume":"70","author":"H Braak","year":"2011","unstructured":"Braak H, Thal DR, Ghebremedhin E, Del Tredici K (2011) Stages of the pathologic process in Alzheimer disease: age categories from 1 to 100\u00a0years. J Neuropathol Exp Neurol 70:960\u2013969","journal-title":"J Neuropathol Exp Neurol"},{"key":"1703_CR8","doi-asserted-by":"crossref","first-page":"901","DOI":"10.3201\/eid1806.120116","volume":"18","author":"P Brown","year":"2012","unstructured":"Brown P, Brandel JP, Sato T, Nakamura Y, MacKenzie J, Will RG et al (2012) Iatrogenic Creutzfeldt\u2013Jakob disease, final assessment. Emerg Infect Dis 18:901\u2013907","journal-title":"Emerg Infect Dis"},{"key":"1703_CR9","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1097\/00005072-199301000-00008","volume":"52","author":"O Bugiani","year":"1993","unstructured":"Bugiani O, Giaccone G, Verga L, Pollo B, Frangione B, Farlow MR et al (1993) Beta PP participates in PrP-amyloid plaques of Gerstmann\u2013Str\u00e4ussler\u2013Scheinker disease, Indiana kindred. J Neuropathol Exp Neurol 52:64\u201370","journal-title":"J Neuropathol Exp Neurol"},{"key":"1703_CR10","first-page":"167","volume-title":"Neuropathology Techniques","author":"TP Dawson","year":"2013","unstructured":"Dawson TP, Neal JW, Llewellyn L, Thomas C (2013) Bielschowsky silver stain. Neuropathology Techniques. Hodder Arnold, London, pp 167\u2013168"},{"key":"1703_CR11","doi-asserted-by":"crossref","first-page":"316","DOI":"10.7326\/M15-2421","volume":"165","author":"G Edgren","year":"2016","unstructured":"Edgren G, Hjalgrim H, Rostgaard K, Lambert P, Wikman A, Norda R et al (2016) Transmission of neurodegenerative disorders through blood transfusion: a cohort study. Ann Intern Med 165:316\u2013324","journal-title":"Ann Intern Med"},{"key":"1703_CR12","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1126\/science.1194516","volume":"330","author":"YS Eisele","year":"2010","unstructured":"Eisele YS, Oberm\u00fcller U, Heilbronner G, Baumann F, Kaeser SA, Wolburg H et al (2010) Peripherally applied Abeta-containing inoculates induce cerebral beta-amyloidosis. Science 330:980\u2013982","journal-title":"Science"},{"key":"1703_CR13","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s00401-015-1516-y","volume":"131","author":"YS Eisele","year":"2016","unstructured":"Eisele YS, Duyckaerts C (2016) Propagation of A\u00df pathology: hypotheses, discoveries, and yet unresolved questions from experimental and human brain studies. Acta Neuropathol 131:5\u201325","journal-title":"Acta Neuropathol"},{"key":"1703_CR14","unstructured":"Exome Aggregation Consortium (ExAC) (version 0.3.1 cited March 2016). http:\/\/exac.broadinstitute.org"},{"key":"1703_CR15","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1038\/nature18602","volume":"535","author":"C Feeney","year":"2016","unstructured":"Feeney C, Scott GP, Cole JH, Sastre M, Goldstone AP, Leech R (2016) Seeds of neuroendocrine doubt. Nature 535:E1\u2013E2","journal-title":"Nature"},{"key":"1703_CR16","first-page":"w14287","volume":"146","author":"K Frontzek","year":"2016","unstructured":"Frontzek K, Lutz MI, Aguzzi A, Kovacs GG, Budka H (2016) Amyloid-\u03b2 pathology and cerebral amyloid angiopathy are frequent in iatrogenic Creutzfeldt\u2013Jakob disease after dural grafting. Swiss Med Wkly 146:w14287","journal-title":"Swiss Med Wkly"},{"key":"1703_CR17","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.brainres.2013.04.052","volume":"1519","author":"M Gahr","year":"2013","unstructured":"Gahr M, Nowak DA, Connemann B, Schonfeldt-Lecuona C (2013) Cerebral amyloid angiopathy\u2014a disease with implications for neurology and psychiatry. Brain Res 1519:19\u201330","journal-title":"Brain Res"},{"key":"1703_CR18","unstructured":"Garrison E, Marth G (2012) Haplotype-based variant detection from shortread sequencing. arXiv:1207.3907v2"},{"key":"1703_CR19","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1056\/NEJM198509193131207","volume":"313","author":"CJ Gibbs Jr","year":"1985","unstructured":"Gibbs CJ Jr, Joy A, Heffner R, Franko M, Miyazaki M, Asher DM et al (1985) Clinical and pathological features and laboratory confirmation of Creutzfeldt\u2013Jakob disease in a recipient of pituitary-derived human growth hormone. N Engl J Med 313:734\u2013738","journal-title":"N Engl J Med"},{"key":"1703_CR20","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1056\/NEJMoa030351","volume":"349","author":"M Glatzel","year":"2003","unstructured":"Glatzel M, Abela E, Maissen M, Aguzzi A (2003) Extraneural pathologic prion protein in sporadic Creutzfeldt\u2013Jakob disease. N Engl J Med 349:1812\u20131820","journal-title":"N Engl J Med"},{"key":"1703_CR21","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1126\/science.1255555","volume":"349","author":"M Goedert","year":"2015","unstructured":"Goedert M (2015) Alzheimer\u2019s and Parkinson\u2019s diseases: the prion concept in relation to assembled A\u03b2, tau and \u03b1-synuclein. Science 349:601\u2013610","journal-title":"Science"},{"key":"1703_CR22","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s00401-016-1588-3","volume":"132","author":"T Hamaguchi","year":"2016","unstructured":"Hamaguchi T, Taniguchi Y, Sakai K, Kitamoto T, Takao M, Murayama S et al (2016) Significant association of cadaveric dura mater grafting with subpial A\u03b2 deposition and meningeal amyloid angiopathy. Acta Neuropathol 132:313\u2013315","journal-title":"Acta Neuropathol"},{"key":"1703_CR23","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1440-1827.2010.02610.x","volume":"61","author":"M Hashizume","year":"2011","unstructured":"Hashizume M, Takagi J, Kanehira T, Otake K, Mimuro M, Yoshida M (2011) Histologic study of age-related change in the posterior pituitary gland focusing on abnormal deposition of tau protein. Pathol Int 61:13\u201318","journal-title":"Pathol Int"},{"key":"1703_CR24","first-page":"1016","volume-title":"Greenfield\u2019s Neuropathology","author":"MW Head","year":"2015","unstructured":"Head MW, Ironside JW, Ghetti B, Jeffrey M, Piccardo P, Will RW (2015) Prion diseases. In: Love S, Budka H, Ironside JW, Perry A (eds) Greenfield\u2019s Neuropathology, 9th edn. CRC Press, Boca Raton, pp 1016\u20131086","edition":"9"},{"key":"1703_CR25","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/j.1440-1789.2011.01273.x","volume":"32","author":"T Homma","year":"2012","unstructured":"Homma T, Mochizuki Y, Mizutani T (2012) Phosphorylated \u03b1-synuclein immunoreactivity in the posterior pituitary lobe. Neuropathology 32:385\u2013389","journal-title":"Neuropathology"},{"key":"1703_CR26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jalz.2011.10.007","volume":"8","author":"BT Hyman","year":"2012","unstructured":"Hyman BT, Phelps CH, Beach TG, Bigio EH, Cairns NJ, Carrillo MC et al (2012) National Institute on Aging-Alzheimer\u2019s Association guidelines for the neuropathologic assessment of Alzheimer\u2019s disease. Alzheimers Dement 8:1\u201313","journal-title":"Alzheimers Dement"},{"key":"1703_CR27","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1007\/BF00293403","volume":"88","author":"SI Ikeda","year":"1994","unstructured":"Ikeda SI, Yanagisawa N, Allsop D, Glenner GG (1994) Gerstmann\u2013Str\u00e4ussler\u2013Scheinker disease showing beta-protein type cerebellar and cerebral amyloid angiopathy. Acta Neuropathol 88:262\u2013266","journal-title":"Acta Neuropathol"},{"key":"1703_CR28","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1001\/jamaneurol.2013.1933","volume":"70","author":"DJ Irwin","year":"2013","unstructured":"Irwin DJ, Abrams JY, Schonberger LB, Leschek EW, Mills JL, Lee VM et al (2013) Evaluation of potential infectivity of Alzheimer and Parkinson disease proteins in recipients of cadaver-derived human growth hormone. JAMA Neurol 70:462\u2013468","journal-title":"JAMA Neurol"},{"key":"1703_CR29","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/nature15369","volume":"525","author":"Z Jaunmuktane","year":"2015","unstructured":"Jaunmuktane Z, Mead S, Ellis M, Wadsworth JD, Nicoll AJ, Kenny J et al (2015) Evidence for human transmission of amyloid-\u03b2 pathology and cerebral amyloid angiopathy. Nature 525:247\u2013250","journal-title":"Nature"},{"key":"1703_CR30","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/nature12481","volume":"501","author":"M Jucker","year":"2013","unstructured":"Jucker M, Walker LC (2013) Self-propagation of pathogenic protein aggregates in neurodegenerative diseases. Nature 501:45\u201351","journal-title":"Nature"},{"key":"1703_CR31","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1101\/gr.210609.116","volume":"27","author":"MJ Keogh","year":"2017","unstructured":"Keogh MJ, Wei W, Wilson I, Coxhead J, Ryan S, Rollinson S et al (2017) Genetic compendium of 1511 human brains available through the UK Medical Research Council Brain Banks Network Resource. Genome Res 27:165\u2013173","journal-title":"Genome Res"},{"key":"1703_CR32","first-page":"37","volume":"135","author":"RH Kimberlin","year":"1988","unstructured":"Kimberlin RH, Walker CA (1988) Pathogenesis of experimental scrapie. Ciba Found Symp 135:37\u201362","journal-title":"Ciba Found Symp"},{"key":"1703_CR33","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/neup.12270","volume":"36","author":"A Kobayashi","year":"2016","unstructured":"Kobayashi A, Parchi P, Yamada M, Mohri S, Kitamoto T (2016) Neuropathological and biochemical criteria to identify acquired Creutzfeldt\u2013Jakob disease among presumed sporadic cases. Neuropathology 36:305\u2013310","journal-title":"Neuropathology"},{"key":"1703_CR34","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1056\/NEJM198509193131206","volume":"313","author":"TK Koch","year":"1985","unstructured":"Koch TK, Berg BO, De Armond SJ, Gravina RF (1985) Creutzfeldt\u2013Jakob disease in a young adult with idiopathic hypopituitarism. Possible relation to the administration of cadaveric human growth hormone. N Engl J Med 313:731\u2013733","journal-title":"N Engl J Med"},{"key":"1703_CR35","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1080\/19336896.2016.1228507","volume":"10","author":"GG Kovacs","year":"2016","unstructured":"Kovacs GG (2016) Can Creutzfeldt\u2013Jakob disease unravel the mysteries of Alzheimer? Prion 10:369\u2013376","journal-title":"Prion"},{"key":"1703_CR36","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1007\/s00401-016-1565-x","volume":"131","author":"GG Kovacs","year":"2016","unstructured":"Kovacs GG, Lutz ML, Ricken R et al (2016) Dura mater is a potential source of A\u03b2 seeds. Acta Neuropathol 131:911\u2013923","journal-title":"Acta Neuropathol"},{"key":"1703_CR37","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1136\/jmg.38.6.353","volume":"38","author":"JC Lambert","year":"2001","unstructured":"Lambert JC, Mann DM, Harris JM, Chartier-Harlin MC, Cumming A, Coates J et al (2001) The \u221248 C\/T polymorphism in the presenilin 1 promoter is associated with an increased risk of developing Alzheimer\u2019s disease and an increased Abeta load in brain. J Med Genet 38:353\u2013355","journal-title":"J Med Genet"},{"key":"1703_CR38","doi-asserted-by":"crossref","first-page":"R25","DOI":"10.1186\/gb-2009-10-3-r25","volume":"10","author":"B Langmead","year":"2009","unstructured":"Langmead B, Trapnekk C, PopM Slazberg SL (2009) Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol 10:R25","journal-title":"Genome Biol"},{"key":"1703_CR39","first-page":"19","volume":"3","author":"S Love","year":"2014","unstructured":"Love S, Chalmers K, Ince P, Esiri M, Attems J, Jellinger K et al (2014) Development, appraisal, validation and implementation of a consensus protocol for the assessment of cerebral amyloid angiopathy in post-mortem brain tissue. Am J Neurodegener Dis 3:19\u201332","journal-title":"Am J Neurodegener Dis"},{"key":"1703_CR40","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/nrmicro1346","volume":"4","author":"NA Mabbott","year":"2006","unstructured":"Mabbott NA, MacPherson GG (2006) Prions and their lethal journey to the brain. Nat Rev Microbiol 4:201\u2013211","journal-title":"Nat Rev Microbiol"},{"key":"1703_CR41","doi-asserted-by":"publisher","unstructured":"Mayeux R, Stern Y (2012) Epidemiology of Alzheimer disease. Cold Spring Harb Perspect Med 2(8). doi: 10.1101\/cshperspect.a006239","DOI":"10.1101\/cshperspect.a006239"},{"key":"1703_CR42","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s00401-015-1515-z","volume":"131","author":"AC McKee","year":"2016","unstructured":"McKee AC, Cairns NJ, Dickson DW, Folkerth RD, Keene CD, Litvan I et al (2016) The first NINDS\/NBIB consensus meeting to define neuropathological criteria for the diagnosis of chronic traumatic encephalopathy. Acta Neuropathol 131:75\u201386","journal-title":"Acta Neuropathol"},{"key":"1703_CR43","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1212\/WNL.41.4.479","volume":"41","author":"SS Mirra","year":"1991","unstructured":"Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM et al (1991) The Consortium to Establish a Registry for Alzheimer\u2019s Disease (CERAD). Part 11. Standardization of the neuropathologic assessment of Alzheimer\u2019s disease. Neurology 41:479\u2013486","journal-title":"Neurology"},{"key":"1703_CR44","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/BF00713522","volume":"83","author":"M Miyazono","year":"1992","unstructured":"Miyazono M, Kitamoto T, Iwaki T, Tateishi J (1992) Colocalization of prion protein and beta protein in the same amyloid plaques in patients with Gerstmann\u2013Str\u00e4ussler syndrome. Acta Neuropathol 83:333\u2013339","journal-title":"Acta Neuropathol"},{"key":"1703_CR45","unstructured":"NHLBI GO Exome Sequencing Project (ESP) (cited 2013 12\/12\/2013). http:\/\/evs.gs.washington.edu\/EVS\/"},{"key":"1703_CR46","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/s00401-009-0585-1","volume":"118","author":"P Parchi","year":"2009","unstructured":"Parchi P, Strammiello R, Notari S, Giese A, Langeveld JP, Ladogana A et al (2009) Incidence and spectrum of sporadic Creutzfeldt-Jakob disease variants with mixed phenotype and co-occurrence of PrPSc types: an updated classification. Acta Neuropathol 118:659\u2013671","journal-title":"Acta Neuropathol"},{"key":"1703_CR47","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/s00401-012-1002-8","volume":"124","author":"P Parchi","year":"2012","unstructured":"Parchi P, de Boni L, Saverioni D, Cohen ML, Ferrer I, Gambetti P et al (2012) Consensus classification of human prion disease histotypes allow reliable identification of molecular subtypes: an inter-rater study among surveillance centres in Europe and USA. Acta Neuropathol 124:517\u2013529","journal-title":"Acta Neuropathol"},{"key":"1703_CR48","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/1531-8249(199908)46:2<224::AID-ANA12>3.0.CO;2-W","volume":"46","author":"P Parchi","year":"1999","unstructured":"Parchi P, Giese A, Capellari S, Brown P, Schulz-Schaeffer W, Windl O et al (1999) Classification of sporadic Creutzfeldt\u2013Jakob disease based on molecular and phenotypic analysis of 300 subjects. Ann Neurol 46:224\u2013233","journal-title":"Ann Neurol"},{"key":"1703_CR49","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/s00401-008-0394-y","volume":"116","author":"C Paquet","year":"2008","unstructured":"Paquet C, Privat N, Kaci R, Polivka M, Dupont O, Ha\u0209k S et al (2008) Cerebral amyloid angiopathy with co-localization of prion protein and beta-amyloid in an 85-year-old patient with sporadic Creutzfeldt\u2013Jakob disease. Acta Neuropathol 116:567\u2013573","journal-title":"Acta Neuropathol"},{"issue":"1","key":"1703_CR50","first-page":"S96","volume":"10","author":"L Peckeu","year":"2016","unstructured":"Peckeu L, Sazdovitch V, Privat N, Welaratne A, Laplanche JL, Seilhan D et al (2016) Iatrogenic CJD after human GH treatment in France: effect of sex, dose and genetics on the susceptibility of a possible infection by a V2 sCJD strain. Prion2016. Tokyo Meet Abstr 10(1):S96","journal-title":"Tokyo Meet Abstr"},{"key":"1703_CR51","doi-asserted-by":"crossref","first-page":"927","DOI":"10.2353\/ajpath.2006.050788","volume":"168","author":"AH Peden","year":"2006","unstructured":"Peden AH, Ritchie DL, Head MW, Ironside JW (2006) Detection and localization of PrPSc in the skeletal muscle of patients with variant, iatrogenic, and sporadic forms of Creutzfeldt\u2013Jakob disease. Am J Pathol 168:927\u2013935","journal-title":"Am J Pathol"},{"key":"1703_CR52","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1099\/vir.0.81913-0","volume":"88","author":"A Peden","year":"2007","unstructured":"Peden A, Ritchie D, Udin HP, Dean AF, Shiller KA, Head MW et al (2007) Abnormal prion protein in the pituitary gland in sporadic and variant Creutzfeldt\u2013Jakob disease. J Gen Virol 88:1068\u20131072","journal-title":"J Gen Virol"},{"key":"1703_CR53","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1097\/WNN.0000000000000071","volume":"28","author":"O Pletnikova","year":"2015","unstructured":"Pletnikova O, Rudow GL, Hyde TM, Kleinman JE, Ali SZ, Bharadwaj R et al (2015) Alzheimer lesions in the autopsied brains of people 30 to 50\u00a0years of age. Cogn Behav Neurol 28:144\u2013152","journal-title":"Cogn Behav Neurol"},{"key":"1703_CR54","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/S0140-6736(85)90292-2","volume":"2","author":"J Powell-Jackson","year":"1985","unstructured":"Powell-Jackson J, Weller RO, Kennedy P, Preece MA, Whitcombe EM, Newsom-Davis J (1985) Creutzfeldt\u2013Jakob disease after administration of human growth hormone. Lancet 2:244\u2013246","journal-title":"Lancet"},{"key":"1703_CR55","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1126\/science.6801762","volume":"216","author":"SB Prusiner","year":"1982","unstructured":"Prusiner SB (1982) Novel proteinaceous infectious particles cause scrapie. Science 216:136\u2013144","journal-title":"Science"},{"key":"1703_CR56","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1146\/annurev-genet-110711-155524","volume":"47","author":"SB Prusiner","year":"2013","unstructured":"Prusiner SB (2013) Biology and genetics of prions causing neurodegeneration. Annu Rev Genet 47:601\u2013623","journal-title":"Annu Rev Genet"},{"key":"1703_CR57","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1007\/s00401-016-1638-x","volume":"133","author":"DL Ritchie","year":"2017","unstructured":"Ritchie DL, Barria MA, Peden AH, Yull HM, Kirkpatrick J, Adlard P et al. (2017) UK Iatrogenic Creutzfeldt-Jakob disease: investigating human prion transmission across genotypic barriers using human tissue-based and molecular approaches. Acta Neuropathol 133:579\u2013595","journal-title":"Acta Neuropathol"},{"key":"1703_CR58","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1111\/j.1365-2990.2003.00544.x","volume":"30","author":"DL Ritchie","year":"2004","unstructured":"Ritchie DL, Head MW, Ironside JW (2004) Advances in the detection of prion protein in peripheral tissues in variant Creutzfeldt\u2013Jakob disease patients using paraffin-embedded tissue blotting. Neuropathol Appl Neurobiol 30:360\u2013368","journal-title":"Neuropathol Appl Neurobiol"},{"key":"1703_CR59","doi-asserted-by":"crossref","first-page":"3386","DOI":"10.1093\/brain\/awv235","volume":"138","author":"P Rudge","year":"2015","unstructured":"Rudge P, Jaunmuktane Z, Adlard P, Bjurstrom N, Caine D, Lowe J et al (2015) Iatrogenic CJD due to pituitary-derived hormone with genetically determined incubation times of up to 40\u00a0years. Brain 138:3386\u20133399","journal-title":"Brain"},{"key":"1703_CR60","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1007\/s00401-014-1340-9","volume":"128","author":"K Sakai","year":"2014","unstructured":"Sakai K, Boche D, Carare R, Johnston D, Holmes C, Love S et al (2014) A\u03b2 immunotherapy for Alzheimer\u2019s disease: effects on apoE and cerebral vasculopathy. Acta Neuropathol 128:777\u2013789","journal-title":"Acta Neuropathol"},{"key":"1703_CR61","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/j.neuron.2014.04.047","volume":"82","author":"DW Sanders","year":"2014","unstructured":"Sanders DW, Kaufman SK, DeVos SL, Sharma AM, Mirbaha H, Li A et al (2014) Distinct tau prion strains propagate in cells and mice and define different tauopathies. Neuron 82:1271\u20131288","journal-title":"Neuron"},{"key":"1703_CR62","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.neuron.2016.01.026","volume":"89","author":"DW Sanders","year":"2016","unstructured":"Sanders DW, Kaufman SK, Holmes BB, Diamond MI (2016) Prions and protein assemblies that convey biological information in health and disease. Neuron 89:433\u2013448","journal-title":"Neuron"},{"key":"1703_CR63","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1677\/joe.0.0940203","volume":"94","author":"J Stein","year":"1982","unstructured":"Stein J, Lester J, Fosten A, Shownkeen RC, Hartree AS (1982) Studies of a human growth hormone preparation used for clinical treatment in Great Britain. J Endocrinol 94:203\u2013210","journal-title":"J Endocrinol"},{"key":"1703_CR64","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1212\/01.WNL.0000084000.27403.15","volume":"61","author":"AJ Swerdlow","year":"2003","unstructured":"Swerdlow AJ, Higgins CD, Adlard P, Jones ME, Preece MA (2003) Creutzfeldt\u2013Jakob disease in United Kingdom patients treated with human pituitary growth hormone. Neurology 61:783\u2013791","journal-title":"Neurology"},{"key":"1703_CR65","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1212\/WNL.58.12.1791","volume":"58","author":"DR Thal","year":"2002","unstructured":"Thal DR, R\u03cbb U, Orantes M, Braak H (2002) Phases of A beta-deposition in the human brain and its relevance for the development of AD. Neurology 58:1791\u20131800","journal-title":"Neurology"},{"key":"1703_CR66","unstructured":"The National Creutzfeldt\u2013Jakob Disease Research & Surveillance Unit. Diagnostic criteria. http:\/\/www.cjd.ed.ac.uk\/sites\/default\/files\/diagnostic%20criteria.pdf . Accessed 31 Jan 2017"},{"key":"1703_CR67","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1111\/neup.12108","volume":"34","author":"T Uchihara","year":"2014","unstructured":"Uchihara T (2014) Pretangles and neurofibrillary changes: similarities and differences between AD and CBD based on molecular and morphological evolution. Neuropathology 34:571\u2013577","journal-title":"Neuropathology"},{"issue":"Suppl l3","key":"1703_CR68","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3233\/JAD-2010-100843","volume":"22","author":"T Vanderweyde","year":"2010","unstructured":"Vanderweyde T, Bednar MM, Forman SA, Wolozin B (2010) Iatrogenic risk factors for Alzheimer\u2019s disease: surgery and anaesthesia. J Alzheimers Dis 22(Suppl l3):91\u2013104","journal-title":"J Alzheimers Dis"},{"key":"1703_CR69","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0140-6736(01)05403-4","volume":"358","author":"JD Wadsworth","year":"2001","unstructured":"Wadsworth JD, Joiner S, Hill AF, Campbell TA, Desbruslais M, Luthert PJ et al (2001) Tissue distribution of protease resistant prion protein in variant Creutzfeldt\u2013Jakob disease using a highly sensitive immunoblotting assay. Lancet 358:171\u2013180","journal-title":"Lancet"},{"key":"1703_CR70","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1016\/S0021-9258(18)34954-8","volume":"257","author":"KH Weisgraber","year":"1982","unstructured":"Weisgraber KH, Innerarity TL, Mahley RW (1982) Abnormal lipoprotein receptor-binding activity of the human E apoprotein due to cysteine-arginine interchange at a single site. J Bio Chem 257:2518\u20132521","journal-title":"J Bio Chem"}],"container-title":["Acta Neuropathologica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00401-017-1703-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-017-1703-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-017-1703-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,26]],"date-time":"2022-07-26T18:20:14Z","timestamp":1658859614000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00401-017-1703-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,27]]},"references-count":70,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["1703"],"URL":"https:\/\/doi.org\/10.1007\/s00401-017-1703-0","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.727459820.793539400","asserted-by":"object"}]},"ISSN":["0001-6322","1432-0533"],"issn-type":[{"value":"0001-6322","type":"print"},{"value":"1432-0533","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,27]]}}}